Interference against a newly labeled substance with ruthenium sulfonate complexes showing discrepant thyroid function test results

• Published in: Clinica chimica acta; international journal of clinical chemistry 2024, Vol.553, p.117706-117706
• Main Authors: Takahashi, Sawako, Nishikawa, Mitsushige, Nishihara, Eijun, Deguchi, Hanna, Kohsaka, Kazuyoshi, Yamaoka, Hiroyuki, Hisakado, Mako, Fukata, Shuji, Ito, Mitsuru, Miyauchi, Akira, Akamizu, Takashi
• Format: Report
• Language: English
• ISSN: 1873-3492
• DOI: 10.1016/j.cca.2023.117706

We report here two patients exhibiting a combination of falsely elevated serum levels of free thyroxine (FT4), free triiodothyronine (FT3), and thyrotropin receptor antibodies (TRAb), measured using Elecsys assay kits (Roche Diagnostics GmbH). The first patient was a 74-year-old man misdiagnosed with Graves' disease and treated with methimazole. The second patient was a 48-year-old woman whose serum FT4 and FT3 concentrations were found to be high during a blood test. These patients denied taking biotin or any other supplements. Further detailed examination, including a heterophilic blocking tube test, revealed the presence of serum antibodies. The abnormal reactions were observed only using the improved assay kits using ruthenium (Ru) sulfonate instead of Ru as a chemiluminescent agent. Therefore, serum antibodies to the Ru sulfonate complex caused the pseudo-high levels of FT4, FT3, and TRAb. To our knowledge, this is the first report showing that antibodies to the Ru sulfonate complex in the electrochemiluminescence immunoassay can cause falsely elevated levels of the combination, leading to discrepant thyroid function test results. We emphasize that in cases of abnormal test results, alternative assay methods should be considered for further examination; unusual test results should not be impulsively interpreted, even when using revised assay kits.